Study Comparing The Tolerability Of Three Excipient Formulations Administered Subcutaneously To Healthy Subjects
NCT01401764
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
OTHER:
Formulation buffers
Sponsor
Ablynx, a Sanofi company